Further to that, Madam Chair, one of the concerns I've heard from patients is that the THC levels, or tetrahydrocannabinol levels, will be vastly changed so that they will not receive the THC level they are expecting, and different strains will provide different medicinal properties to them.
I wonder if you could speak to that a bit from the perspective that the new program will potentially regulate the types of strains that will be available to patients.